Sugen

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

60

By Phase

NA: 1PHASE2: 1

By Status

COMPLETED: 2

Clinical Trials Pipeline

No trials with date information available

Recent Trials

NCT00002226Lead Sponsor

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

30 participants

NCT00005931Lead Sponsor

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

PHASE2Completed

30 participants

Funding History (10)

DEFM14A

Aug 3, 1999

8-K

Aug 2, 1999

8-K

Jun 21, 1999

DEF 14A

Apr 20, 1999

8-K

Mar 29, 1999

DEF 14A

Apr 17, 1998

8-K

Nov 18, 1997

8-K

Oct 27, 1997

8-K

Sep 18, 1997

DEF 14A

Apr 9, 1997

Related Companies

Pharmacia & Upjohn

acquired